Previous 10 | Next 10 |
home / stock / erfsf / erfsf news
Giverny Capital Asset Management, LLC is a partnership between Giverny Capital of Montreal and David Poppe, the former president and chief executive officer of Ruane, Cunniff & Goldfarb, LLC. For the second quarter of 2022, Giverny Capital Asset Management’s model portfolio...
Ruane, Cunniff, & Goldfarb’s 13F portfolio value decreased from $11.71B to $10.15B this quarter. The number of positions remained steady at 34. They increased Netflix while almost selling out Walt Disney. The top three positions are Alphabet, UnitedHealth, and Anthem an...
Giverny Capital Asset Management, LLC is a partnership between Giverny Capital of Montreal and David Poppe, the former president and chief executive officer of Ruane, Cunniff & Goldfarb, LLC. Volatility, after all, is what creates the occasional dislocations in the market that all...
Ruane, Cunniff & Goldfarb’s 13F portfolio value increased from $11.13B to $11.71B this quarter. The number of positions increased from 33 to 34. They increased Wayfair while reducing Credit Acceptance and Berkshire Hathaway. The top three positions are Alphabet, UnitedH...
Eurofins Scientific (OTCPK:ERFSF) announces a share purchase agreement with Transgenic to acquire Genetic Lab, a molecular biology based testing provider for diagnostics, biomarker development and drug discovery. Initially established as a genetics technology based bio venture in 2000, G...
Ruane, Cunniff & Goldfarb’s 13F portfolio value increased from $10.63B to $11.28B this quarter. The number of positions decreased from 37 to 35. They increased Micron Technology, Anthem, and Netflix while reducing Jacobs Engineering and Arista Networks during the quarter. T...
Ruane, Cunniff, & Goldfarb’s 13F portfolio value increased from $9.38B to $10.63B this quarter. The number of positions decreased from 38 to 37. They added Micron Technology and Anthem, Inc. while reducing Mastercard, Visa, Berkshire Hathaway, Wayfair, and Arista Networks d...
Eurofins showed rock-solid performance in 2020 and Q1 2021. The third wave of coronavirus and slower-than-expected vaccination rates in Europe mean that Covid-19 testing will contribute to revenue growth throughout 2021 and 2022. It seems that the stock is close to a plateau. ...
Ruane, Cunniff, & Goldfarb’s 13F portfolio value increased from $8.40B to $9.38B this quarter. The number of positions increased from 35 to 38. They added Netflix and increased Credit Acceptance Corp while reducing Wayfair during the quarter. The top three positions are...
Eurofins donates 100,000 fast PCR tests to detect SARS-CoV-2 variants B.1.1.7 (ex. UK), B.1.351 (ex. South Africa) and B1.1.248 (ex. Brazil) to hospitals around the world PR Newswire DUBLIN , Feb. 2, 2021 /PRNewswire/ -- Eurofins is making new assays for the ...
News, Short Squeeze, Breakout and More Instantly...
Eurofins Scientific S.E. Company Name:
ERFSF Stock Symbol:
OTCMKTS Market:
Eurofins CDMO Alphora Inc. is excited to announce an expansion of its API capacity and capabilities with the completion of its new API manufacturing facility at its site in Mississauga, Canada. The new API facility adds 15,000 sq ft of GMP processing and warehousing space which complements Eurofi...
The Eurofins network of companies, a world leader in food, environment, pharmaceutical and cosmetic product testing, announces the completion of the acquisition of Labormar. The acquisition will further strengthen the Eurofins network’s global food and feed, cosmetic and pharmacological, a...
China Yuchai International Limited (CYD) is expected to report for Q1 2024 Avid Bioservices Inc. (CDMO) is expected to report $0.03 for Q4 2024 Derwent London Plc (DWVYF) is expected to report for Q1 2024 Fresnillo Plc (FNLPF) is expected to report for Q1 2024 Basilea Pharmaceutic...